Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-04

Clinical Trial Update: Use of Clobazam for Epilepsy and Anxiety [Phase 4]

View source ↗

Summary

Phase 4 trial update on the use of clobazam for epilepsy and anxiety has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBAZAM (CLOBAZAM)

Snippet

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Conditions: Epilepsy, Anxiety | Phase 4 | Status: COMPLETED | Results posted: 2021-03-04